Sio Capital Management, LLC Axsome Therapeutics, Inc. Transaction History

Sio Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$16.71 - $106.24 $339,380 - $2.16 Million	-20,310 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$13.46 - $25.75 $297,466 - $569,075	-22,100 Reduced 52.11%	20,310 $523,000
Q1 2019 May 15, 2019	SELL	$2.63 - $16.34 $889,997 - $5.53 Million	-338,402 Reduced 88.86%	42,410 $603,000
Q4 2018 Feb 14, 2019	SELL	$2.0 - $4.15 $71,292 - $147,930	-35,646 Reduced 8.56%	380,812 $1.07 Million
Q3 2018 Nov 14, 2018	BUY	$2.3 - $3.55 $513,286 - $792,246	223,168 Added 115.46%	416,458 $1.44 Million
Q1 2018 May 15, 2018	BUY	$2.35 - $5.6 $454,231 - $1.08 Million	193,290 New	193,290 $474,000

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.73B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.